ArticleACS nanoscience Au2025
Incorporation of a Natural Deep Eutectic Solvent-Based System as a Cryoprotectant in Solid Lipid Nanoparticles: Advancing toward Industrial Scalability.
Article in ACS nanoscience Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The industrial-scale production of solid lipid nanoparticles (SLNs) faces significant challenges, such as degradation during freezing and the reliance on toxic solvents for cryoprotection and active ingredient solubility, hindering their effective storage and commercialization. This study presents an innovative and sustainable approach to SLNs formulation by incorporating a natural deep eutectic solvent-based system (NaDES) as an integral part of the system. The research evaluated the cryoprotective potential of NaDES at different concentrations and freezing methods, demonstrating their ability to stabilize aluminum chloride phthalocyanine (AlClPc)-loaded SLNs during freezing and enable drying protocols to enhance particle concentration. SLNs formulations with high colloidal stability were obtained, containing 12.5% NaDES, based on low-energy methodologies and high added value. Additionally, the use of NaDES enabled a 12.5% reduction in the water content in the formulation and acted as an efficient cryoprotectant, allowing for the freezing of SLNs without compromising particle integrity. These advancements suggest a greener and potentially scalable methodology for SLNs production, positioning NaDESs as promising cryoprotectants that may enhance formulation stability, improve commercial viability, and reduce production and storage costs. This innovation may represent an initial step toward improving nanoparticle preservation and facilitating future industrial translation, with the potential to broaden nanoparticle application in nanotechnology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.